Healthcare provider profile · identity verified

Leslie Kirschner, CNP

Nurse Practitioner · WARRENSVILLE HEIGHTS, OH · NPI 1467852467

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Furosemide	Furosemide	551	78
Levothyroxine Sodium	Levothyroxine Sodium	549	78
Atorvastatin Calcium	Atorvastatin Calcium	474	64
Amlodipine Besylate	Amlodipine Besylate	390	58
Potassium Chloride	Potassium Chloride	311	44
Sertraline Hcl	Sertraline Hcl	311	44
Donepezil Hcl	Donepezil Hcl	296	37
Memantine Hcl	Memantine Hcl	273	34
Gabapentin	Gabapentin	267	41
Mirtazapine	Mirtazapine	252	39
Lisinopril	Lisinopril	238	30
Trazodone Hcl	Trazodone Hcl	233	34
Eliquis	Apixaban	228	37
Quetiapine Fumarate	Quetiapine Fumarate	228	40
Pantoprazole Sodium	Pantoprazole Sodium	216	39
Simvastatin	Simvastatin	214	23
Tamsulosin Hcl	Tamsulosin Hcl	190	22
Buspirone Hcl	Buspirone Hcl	177	30
Losartan Potassium	Losartan Potassium	175	25
Metoprolol Tartrate	Metoprolol Tartrate	171	24
Clopidogrel	Clopidogrel Bisulfate	161	23
Omeprazole	Omeprazole	159	27
Metoprolol Succinate	Metoprolol Succinate	155	21
Hydroxyzine Hcl	Hydroxyzine Hcl	125	31
Divalproex Sodium	Divalproex Sodium	112	25
Metformin Hcl	Metformin Hcl	111	20
Venlafaxine Hcl Er	Venlafaxine Hcl	108	12
Cephalexin	Cephalexin	101	55
Escitalopram Oxalate	Escitalopram Oxalate	97	19
Hydrochlorothiazide	Hydrochlorothiazide	96	13
Rosuvastatin Calcium	Rosuvastatin Calcium	93	16
Spironolactone	Spironolactone	90	17
Finasteride	Finasteride	85	12
Torsemide	Torsemide	74	15
Alendronate Sodium	Alendronate Sodium	71	suppressed
Carvedilol	Carvedilol	70	suppressed
Tramadol Hcl	Tramadol Hcl	69	15
Olanzapine	Olanzapine	65	13
Famotidine	Famotidine	64	11
Xarelto	Rivaroxaban	60	suppressed
Allopurinol	Allopurinol	57	12
Latanoprost	Latanoprost	57	14
Oxybutynin Chloride	Oxybutynin Chloride	55	suppressed
Citalopram Hbr	Citalopram Hydrobromide	54	15
Prednisone	Prednisone	53	19
Warfarin Sodium	Warfarin Sodium	53	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	51	suppressed
Pravastatin Sodium	Pravastatin Sodium	48	suppressed
Myrbetriq	Mirabegron	46	suppressed
Ondansetron Hcl	Ondansetron Hcl	46	32
Fluoxetine Hcl	Fluoxetine Hcl	44	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	41	31
Levetiracetam	Levetiracetam	40	suppressed
Meloxicam	Meloxicam	40	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	40	25
Atenolol	Atenolol	39	suppressed
Duloxetine Hcl	Duloxetine Hcl	39	suppressed
Hydralazine Hcl	Hydralazine Hcl	39	suppressed
Ezetimibe	Ezetimibe	37	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	36	12
Nystatin	Nystatin	35	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Lorazepam	Lorazepam	34	suppressed
Risperidone	Risperidone	34	suppressed
Glimepiride	Glimepiride	33	suppressed
Lamotrigine	Lamotrigine	33	suppressed
Metformin Hcl Er	Metformin Hcl	32	suppressed
Aripiprazole	Aripiprazole	31	suppressed
Amiodarone Hcl	Amiodarone Hcl	30	suppressed
Levofloxacin	Levofloxacin	30	25
Humalog Kwikpen U-100	Insulin Lispro	29	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	29	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	28	suppressed
Baclofen	Baclofen	26	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	26	suppressed
Rivastigmine	Rivastigmine Tartrate	26	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	23	suppressed
Oxcarbazepine	Oxcarbazepine	22	suppressed
Digoxin	Digoxin	21	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	suppressed
Mycophenolate Mofetil	Mycophenolate Mofetil	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Primidone	Primidone	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	17
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Verapamil Hcl	Verapamil Hcl	19	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Loperamide	Loperamide Hcl	18	12
Raloxifene Hcl	Raloxifene Hcl	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Valsartan	Valsartan	18	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Naproxen	Naproxen	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	11
Estradiol	Estradiol	14	suppressed
Labetalol Hcl	Labetalol Hcl	14	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Trimethoprim	Trimethoprim	14	suppressed
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Montelukast Sodium	Montelukast Sodium	13	suppressed
Nebivolol Hcl	Nebivolol Hcl	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Azathioprine	Azathioprine	12	suppressed
Azithromycin	Azithromycin	12	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Flecainide Acetate	Flecainide Acetate	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Dicloxacillin Sodium	Dicloxacillin Sodium	11	suppressed
Ingrezza	Valbenazine Tosylate	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Propranolol Hcl	Propranolol Hcl	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error